Articles

August 11, 2010 – The Bluhm Cardiovascular Institute of Northwestern Memorial Hospital recently implanted a patient with two of the smallest experimental ventricular assist devices (VADs)...

Cardiac rhythm device reliability and the approach to managing complications associated with these devices have recently been the topic of numerous medical and nonmedical publications.

In addition to the FDA-cleared Gore Helex and the AGA Amplatzer transcatheter devices for atrial septal defects (ASDs), there are several others in development or already cleared for use outside...

Transcatheter structural heart repair devices deployed in the cath lab have largely replaced open-heart surgery as the therapy of choice. Percutaneously deployed septal occluders make it possible...

There is no consensus about whether atherosclerotic renal artery stenosis should be stented or treated medically. There are strong opinions on both sides and clinical data up to now is heavily...

Outside the United States, transradial artery access is used in 50-90 percent of percutaneous interventions over femoral access, while U.S. usage rates are less than 5 percent. However, a patient...

Transradial access is slowly gaining ground in the United States as more physicians make the switch due to greatly reduced bleeding complications, increased patient comfort and earlier ambulation...

The barriers that once separated interven-tionalists, cardiac surgeons, vascular surgeons and electrophysiologists are rapidly being reduced by the convergence of transcatheter technologies and...

Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality. These devices control contrast dosage, record the amount used, speed...

Pulmonary embolism (PE) is generally treated with blood thinners, but a more aggressive treatment may be required for massive PE in hemodynamically compromised patients, said Ali Amin, M.D., a...